MRSN vs TYL · rev $40.5M vs P/E 89, rev $1.26B
Mersana Therapeutics Inc (MRSN) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
MRSN currently screens at market cap $145.4M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the MRSN and TYL stock pages for the full models.
Not investment advice.